Isoray, Inc. Announces Pricing of $9.5 Million Public Offering

RICHLAND, Wash., October 20, 2020 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, announced the pricing of its public offering of 18,269,230 shares of...

Isoray, Inc. Announces Proposed Underwritten Public Offering

RICHLAND, Wash., October 19, 2020 — Isoray, Inc. (NYSE AMERICAN: ISR) (“Isoray” or the “Company”), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that it intends to offer...